ArticleFrontiers in immunology2022

Microwave ablation and synchronous transarterial chemoembolization combined with PD-1 inhibitor in patients with hepatocellular carcinoma following tyrosine kinase inhibitor intolerance.

Qin Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.